COMMUNIQUÉS West-GlobeNewswire

Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal

22/04/2025 - 02:00

San Antonio, TX, April 21, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today reported [...]

HUTCHMED Completes Patient Enrollment of a Phase II Registration Study of Savolitinib in Gastric Cancer in China

22/04/2025 - 02:00

HONG KONG and FLORHAM PARK, N.J., April 22, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has completed enrollment of the registration phase of its [...]

UPDATE -- Opreme Films announces “Just Blood”: A Medical Demonstration Poised to Rewrite Theranos Story

22/04/2025 - 04:02

Ryan El-Hosseiny Declares Elizabeth Holmes Was Right All Along—And Plans to Prove It Live! MIAMI BEACH, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- In a moment destined to shake the foundation of modern medicine—and [...]

Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio

21/04/2025 - 22:05

New system features higher viscoelastic capacity and TruSync™ technology, engineered to safely synchronize surgical control and precision in implant-free, comprehensive MIGS MENLO PARK, Calif., April 21, 2025 (GLOBE [...]

AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer

21/04/2025 - 22:05

– Former CEO, Marc Forth, to remain as a member of the Company’s Board of Directors – IRVINE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage [...]

Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025

21/04/2025 - 22:05

CARLSBAD, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended March 31, 2025, before the market opens on [...]

NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

21/04/2025 - 22:05

The FDA d esignation m arks a s ignificant m ilestone in the d evelopment of a n ovel t reatment for a r are n eurodevelopmental d isorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidate for [...]

Regeneron Announces Investor Conference Presentations

21/04/2025 - 22:05

TARRYTOWN, N.Y., April 21, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) will webcast management participation as follows: BofA Securities 2025 Health Care Conference at 10:00 a.m. PT (1:00 p. [...]

Clover Health to Participate in Upcoming Investor Conferences

21/04/2025 - 22:05

WILMINGTON, Del., April 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following investor conferences [...]

Myriad Genetics Announces Study Results Show Patients with Depression had Fewer Psychiatric Hospitalizations after GeneSight Testing

21/04/2025 - 22:05

Study published in the Journal of Clinical Psychopharmacology SALT LAKE CITY, April 21, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, [...]

Galapagos Announces Executive Leadership Updates

21/04/2025 - 22:10

Mr. Henry Gosebruch appointed by the Galapagos Board of Directors as founding CEO of newly created SpinCo Dr. Paul Stoffels, Chair and CEO of Galapagos, plans to retire as CEO upon appointment of successor in the next [...]

Bringing clarity and precision to the cell-free space by introducing exozymes

21/04/2025 - 22:10

Scientific definition of exozymes featured as cover story in GEN Biotechnology, freely available as an Open Access paper The author team introduces the terms ‘exozymes’ to bring clarity to the rapidly evolving field of [...]

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

21/04/2025 - 22:10

IRVINE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the [...]

LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025

21/04/2025 - 22:10

SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its first quarter 2025 earnings [...]

Precision Optics to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

21/04/2025 - 22:15

Company to conduct 1x1 meetings on April 24, 2025 GARDNER, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments [...]

Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

21/04/2025 - 22:15

Company to conduct 1x1 meetings on April 24, 2025 GAITHERSBURG, Md., April 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and [...]

Pennant Announces First Quarter 2025 Earnings Release and Call

21/04/2025 - 22:27

EAGLE, Idaho, April 21, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it [...]

Revive Therapeutics Announces Proposed Shares for Debt Transaction

21/04/2025 - 22:30

TORONTO, April 21, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of [...]

Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development

21/04/2025 - 22:30

AUSTIN, Texas, April 21, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a clinical-stage biotechnology company focused on developing novel, investigational treatments, [...]